Background. Ultrasound, genetic and clinical correlations are available for
ADPKD-1, but lacking for ADPKD-2. The present study was carried out to add
ress: (i) the age-related diagnostic usefulness of ultrasound compared with
genetic linkage studies; (ii) the age-related incidence and prevalence of
relevant symptoms and complications; and (iii) the age and causes of death
in patients with ADPKD-2.
Methods. Two hundred and eleven alive subjects, from three ADPKD-2 families
at 50% risk, were evaluated by physical examination, consultation of hospi
tal records, biochemical parameters, ultrasound and with genetic linkage an
d DNA mutation analyses. Nineteen deceased and affected family members were
;also included in the study.
Results. Of the 211 alive members, DNA linkage studies and direct mutation
analyses showed that 106 were affected and 105 were not. Ultrasound indicat
ed 94 affected, 108 not affected and nine equivocal results in nine childre
n under the age of 15. For all ages, the false-positive diagnostic rate for
ultrasound was 7.5% and the false-negative rate was 12.9%. The difference
between ultrasound and DNA findings was most evident in children aged 5-14
years where the ultrasound was correct in only 50% and wrong or inconclusiv
e in the remaining 50%. The mean age of the 106 alive, ADPKD-2 genetically
affected patients was 37.9 years (range: 6-66 years). Among them, 23.5% had
experienced episodes of renal pain, 22.6% were treated for hypertension, 2
2.6% had experienced at least one urinary tract infection, 19.8% had nephro
lithiasis, 11.3% had at least one episode of haematuria, 9.4% had asymptoma
tic liver cysts, 7.5% had developed chronic renal failure and 0.9% had reac
hed end-stage renal failure. Of the 19 deceased members, nine died before r
eaching end-stage renal failure at a mean age of 58.7 years (range: 40-68 y
ears), mainly due to vascular complications,while the remaining 10 died on
haemodialysis at a mean age of 71.4 years (range: 66-82 years).
Conclusions. DNA analysis is the gold standard for the diagnosis of ADPKD-2
, especially in young people. Ultrasound diagnosis is highly dependent on a
ge. Under the age of 14, ultrasound is not recommended as a routine diagnos
tic procedure, but ultrasound becomes 100% reliable in excluding ADPKD-2 in
family members at 50% risk, over the age of 30. ADPKD-2 represents a mild
variant of polycystic kidney disease with a low prevalence of symptoms and
a late onset of end-stage renal failure.